First canine insulin drug

NewsGuard 100/100 Score

FDA has approved a porcine insulin zinc suspension product as the first drug for treating diabetic dogs. Prior to the development of this product, the only treatment veterinarians could use on diabetic dogs was human insulin, which is less compatible with a dog’s metabolic system.

Estimates are that one in every 200 dogs will develop diabetes. The onset usually occurs in dogs aged 7-9 years, and seems to be twice as prevalent in females as in males.

“This is a very positive development for millions of American dog owners and their pets,” said Acting FDA Commissioner Dr. Lester M. Crawford. “It promises to improve the health and quality of life of dogs who suffer from this debilitating disease.”

The product will be marketed under the trade name “Vetsulin” by its developer Intervet, Inc. of Millsboro, Del., and will be available under a veterinarian’s prescription.

The treatment will be used to improve the clinical signs of diabetes in dogs such as excessive thirst, excessive urination, excessive appetite, and weight loss despite good appetite.

Veterinarians will determine the initial treatment dose based on the dog’s weight, and then will use various tests to adjust the dosage to the optimum level.

Maintenance administration of the insulin may be done in the home. Dog owners will be provided instructions on how to treat their dogs at home with the insulin. An information sheet that outlines the benefits and risks of the treatment will also be provided.

Among the risks dog owners may face is hypoglycemia (dangerously lowblood sugar) if they accidentally inject themselves with the insulin. The product contains warning statements on the label about this risk as well as others such as the need to prevent eye exposure to the insulin.

Vetsulin has already been approved in 20 countries, including the United Kingdom, and should be available in the United States in late summer 2004.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Milestone in diabetes treatment: Transgenic cow produces human insulin in milk